Xometry (XMTR): Director Emily Rollins Exercises 350 Options

Emily Rollins, a director of Xometry, Inc. (XMTR), executed stock-option transactions on 08/11/2025.

Rhea-AI Filing Summary

Emily Rollins, a director of Xometry, Inc. (XMTR), executed stock-option transactions on 08/11/2025. The filing shows the exercise/conversion of a stock option with an exercise price of $12.32 to acquire 350 shares of Class A common stock, increasing her direct beneficial ownership to 11,455 shares. Table II lists the option details (exercise price $12.32; 350 options; expiration 02/24/2031) and notes the options are fully vested.

The Form 4 was signed by Kristie Scott as attorney-in-fact on 08/12/2025 and filed as a Form 4 reporting transaction code M. No amendments or other transactions are reported in the provided content.

Positive

• Director acquired 350 shares through a reported option exercise, an explicit, disclosed insider transaction.
• Options were fully vested, as stated in the filing, removing vesting contingency for the reported exercise.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine insider option exercise—350 shares acquired at $12.32; disclosure appears standard and not materially dilutive.

The filing documents a director-level exercise of 350 stock options on 08/11/2025 at an exercise/conversion price of $12.32, resulting in 11,455 shares beneficially owned directly. The options are noted as fully vested and the form was executed by an attorney-in-fact. This is a standard Section 16 disclosure of a director option exercise with no other compensatory or unusual terms disclosed in the document.

Corporate Governance Expert

TL;DR: Director exercise and standard Form 4 filing; fully vested options recorded and signed by attorney-in-fact.

The record shows routine reporting compliance: a director exercised options to acquire 350 Class A shares, exercise price $12.32, with the derivative details and expiration date (02/24/2031) included and a note that the options are fully vested. The Form 4 is signed by an attorney-in-fact on 08/12/2025. Based on the data in this filing alone, the disclosure meets standard insider reporting requirements and contains no additional governance concerns.

Insider Trade Summary

350 shares exercised/converted

Exercise 2 txns

Insider Rollins Emily

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	350	$0.00	$0.00
Exercise	Class A Common Stock	350	$12.32	$4K

Holdings After Transaction: Stock Option (Right to Buy) — 350 contracts (Direct); Class A Common Stock — 11,455 shares (Direct)

Footnotes (1)

1. F1. Fully vested.

FAQ

What did Emily Rollins report on Form 4 for XMTR?

Acquired 350 shares via exercise of stock options on 08/11/2025 at an exercise price of $12.32, increasing holdings to 11,455 shares.

How many options were exercised and at what price in the XMTR Form 4?

350 options were exercised at an exercise/conversion price of $12.32.

What is Emily Rollins' beneficial ownership after the reported transaction?

11,455 shares beneficially owned directly following the reported transaction.

Are the exercised options vested according to the filing?

Yes; the filing explicitly states the options are fully vested.

Who signed the Form 4 and when was it signed?

Kristie Scott, Attorney-in-Fact, signed the Form 4 on 08/12/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2025 - 04:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rollins Emily

(Last) (First) (Middle)

C/O XOMETRY, INC.

6116 EXECUTIVE BLVD, SUITE 800

(Street)

NORTH BETHESDA MD 20852

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Xometry, Inc. [ XMTR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/11/2025		M		350	A	$12.32	11,455	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$12.32	08/11/2025		M			350	(1)	02/24/2031	Class A Common Stock	350	$0.00	350	D

Explanation of Responses:

1. Fully vested.

Remarks:

	/s/ Kristie Scott, Attorney-in-Fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.